Life Sciences Practice
Group Leader: Bill Wofford

Hutchison Law Group provides legal counsel and networking assistance to many life sciences companies, most of them bringing improved health care products and services to the public. Our life sciences practices group is competitive with similar legal practices around the country in terms of value delivered, capabilities and sophistication. Hutchison Law Group's concentrated work in life sciences in the Research Triangle area has been the key factor in our high life sciences profile and achievements.

Our Clients
Hutchison Law Group clients are engaged in the following life science businesses, among others:
  • Synthesizing and testing novel chemical compounds
  • Developing advanced technologies for drug screening
  • Providing tools to automate drug discovery
  • Developing genetic tests for personalized medicine
  • Providing preclinical and clinical trial services
  • Developing prophylactic and therapeutic vaccines
  • Creating novel devices and systems for drug delivery
  • Developing improved surgical devices
  • Developing radiation monitoring devices
  • Conducting diagnostic tests
  • Supplying advanced imaging hardware and software
  • Providing regulatory compliance software and services
  • Manufacturing and distributing prescription and over the counter medicines
  • Marketing pharmaceutical products
  • Providing staffing and management services for healthcare providers
  • Producing software to improve medical claims management
Hutchison Law Group often begins working with entrepreneurs throughout the Southeast at the inception of their companies. We help clients transform innovative technologies into real-world dynamic companies and often serve each client continually until it becomes part of a much larger organization. We also assist larger U.S. and international companies expand their life sciences businesses through patent prosecution, corporate partnerships and acquisitions. Our hallmark behavior is our determination to develop partnerships with clients, assisting them in ways that reach well beyond conventional legal counsel.

Our Services
Our work with life science companies is concentrated in five areas:
  • Launching new companies based on novel intellectual property and technology
  • Capturing and protecting intellectual property through patent, trademark and other means
  • Raising capital to fund research, development and commercialization
  • Structuring and negotiating licenses and other commercial partnerships
  • Achieving shareholder liquidity through public offerings and negotiated mergers and acquisitions
Our attorneys have the legal and transactional experience to assist clients make operational and strategic decisions to build and capture value. The life sciences group builds value by helping to acquire, develop and manage patent estates. We help clients maximize value by structuring transactions to capitalize on intellectual property. We are adept at negotiating and closing deals and thoroughly enjoy achieving these successes on behalf of our business partners.

We regularly represent clients in the preparation, review, and negotiation of a wide variety of agreements, including the following:
Patent license Process chemistry
Collaboration Distribution
Research Manufacturing and supply agreements
Material transfer Chemical synthesis
Technology transfer Strategic alliance
Drug discovery Confidentiality
Drug development Settlement

Our attorneys also advise life science companies on public and private securities law and regulatory matters, venture capital, loan and other financings, government and foundation grants and contracts, mergers and acquisitions, employment and other general corporate matters. Our trademark attorneys help protect brand portfolios through trademark and domain name selection and protection, and copyright applications. Our patent attorneys also conduct due diligence, freedom-to-operate analysis, and product clearances.

We are active members of the Council for Entrepreneurial Development, Licensing Executives Society, North Carolina Biosciences Organization and the American Bar Association's Biotechnology Committee. We support the North Carolina Biotechnology Center, the Southeastern Life Sciences Association and university technology commercialization initiatives throughout the Southeast.
Life Sciences
Research Institutions
Information Technology

Who Wants to Be a Biotech Millionaire?
Look North: Canadian Incentives May Help Finance U.S. Technology Start-Ups
Bashir M.S. Ali, Ph.D.
Jennifer M. Ball
Allen R. Baum
Glen E. Caplan
Holly A. Coldiron
Joshua T. Elliott
John M. Fogg
Christopher E. Fulmer
Thomas E. Holsten
Fred D. Hutchison
Justyn J. Kasierski
Helga L. Leftwich
Emily H. Margolis
Allyn B. Rhodes
Caroline Horton Rockafellow
Bryan L. Skelton, Ph.D.
Amalie L. Tuffin
Randall M. Whitmeyer
William N. Wofford